Abstract
Streptomyces platensis MA7327 is a bacterium producing interesting antibiotics, which act by the novel mechanism of inhibiting fatty acid biosynthesis. The antibiotics produced by this actinomycete are platensimycin and platencin plus some minor related antibiotics. Platensimycin and platencin have activity against antibiotic-resistant bacteria such as methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus; they also lack toxicity in animal models. Platensimycin also has activity against diabetes in a mouse model. We have been interested in studying the effects of primary metabolites on production of these antibiotics in our chemically defined production medium. In the present work, we tested 32 primary metabolites for their effect. They included 20 amino acids, 7 vitamins and 5 nucleic acid derivatives. Of these, only l-aspartic acid showed stimulation of antibiotic production. We conclude that the stimulatory effect of aspartic acid is due to its role as a precursor involved in the biosynthesis of aspartate-4-semialdehyde, which is the starting point for the biosynthesis of the 3-amino-2,4-dihydroxy benzoic acid portion of the platensimycin molecule.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Laxminarayan, R. et al. Antibiotic resistance-the need for global solutions. Lancet Inf. Dis. 13, 1057–1098 (2013).
Allahverdiyev, A. M. et al. The use of platensimycin and platencin to fight antibiotic resistance. Infect. Drug Res. 6, 99–114 (2013).
Klevens, R. M. et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298, 1763–1771 (2007).
Courvalin, P. Vancomycin resistance in gram-positive cocci. Clin. Infect. Dis. 42, S25–S34 (2006).
Wang, J. et al. Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties. Proc. Natl Acad. Sci. USA 104, 7612–7616 (2007).
Wang, J. et al. Platensimycin is a selective FabF inhibitor with potent antibiotic properties. Nature 441, 358–361 (2006).
Singh, S. B. & Young, K. New antibiotic structures from fermentations. Expert Opin. Ther. Pat 20, 1359–1371 (2010).
Tiefenbacher, K. & Mulzer, J. A nine-step total synthesis of (−)-platencin. J. Org. Chem. 74, 2937–2941 (2009).
Brown, A. K. et al. Platensimycin activity against mycobacterial P-ketoacyl-ACP synthases. PLoS ONE 4, 1–10 (2009).
Ashforth, E. J. et al. Bioprospecting for antituberculosis leads from microbial metabolites. Nat. Prod. Rep. 27, 1709–1719 (2010).
Wu, M. et al. Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetes. Proc. Natl Acad. Sci. USA 108, 5378–5384 (2011).
Singh, S. B. Drug Discovery from Natural Products (eds Genilloud, O. & Vicente, F.) Ch. 12, 249–277 (Royal Society of Chemistry, Cambridge, UK, 2012).
Martens, E. & Demain, A. L. Platensimycin and platencin: promising antibiotics for future application in human medicine. J. Antibiot. 64, 705–710 (2011).
Herath, K. et al. Biosynthetic studies of platencin. Tetrahedron Lett. 49, 6265–6268 (2008).
Herath, K. et al. Biosynthetic studies of platensimycin. J. Am. Chem. Soc. 129, 15422–15423 (2007).
Berg, J. M. et al Biochemistry 7th edn, 499–511; 710-714 (W. H. Freeman and Company, New York, NY, 2012)..
Smanski, M. et al. Dedicated ent-kaurene and ent-atiserene synthases for platensimycin and platencin biosynthesis. Proc. Natl Acad. Sci. USA 108, 13498–13503 (2011).
Dairi, T. Studies on the biosynthetic genes and enzymes of isoprenoids produced by actinomycetes. J. Antibiot. 58, 227–243 (2005).
Aluotto, S. et al. Development of a semi-defined medium supporting production of platensimycin and platencin by Streptomyces platensis. J. Antibiot. 66, 51–54 (2013).
Falzone, M. et al. Development of a chemically defined medium for the production of the antibiotic platensimycin by Streptomyces platensis. Appl. Microbiol. Biotechnol. 97, 9535–9539 (2013).
Acknowledgements
We acknowledge the encouragement by RISE Director Dr Jon Kettenring, and the assistance of RISE Administrative Assistant Miriam Donohue and Nilya Schaber, RISE/ResMed Program Coordinator.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Falzone, M., Crespo, E., Jones, K. et al. Nutritional control of antibiotic production by Streptomyces platensis MA7327: importance of l-aspartic acid. J Antibiot 70, 828–831 (2017). https://doi.org/10.1038/ja.2017.49
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ja.2017.49
